The use of antibody engineering to create novel drugs that target N-methyl-D-aspartate receptors

Joseph R. Moskal*, Hirotaka Yamamoto, Patricia A. Colley

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'The use of antibody engineering to create novel drugs that target N-methyl-D-aspartate receptors'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds